Overcoming acquired MET amplification after encorafenib-cetuximab in BRAF-V600E mutated colorectal cancer

被引：6
|
作者：
Ros, Javier [1 ]
Elez, Elena [1 ]
机构：
[1] Vall DHebron Hosp, Med Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 172卷
关键词：
D O I：
10.1016/j.ejca.2022.06.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 328
页数：3
相关论文
共 50 条
  • [41] Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
    Boccaccino, A.
    Borelli, B.
    Intini, R.
    Antista, M.
    Bensi, M.
    Rossini, D.
    Passardi, A.
    Tamberi, S.
    Giampieri, R.
    Antonuzzo, L.
    Noto, L.
    Roviello, G.
    Zichi, C.
    Salati, M.
    Puccini, A.
    Noto, C.
    Parisi, A.
    Rihawi, K.
    Persano, M.
    Crespi, V
    Libertini, M.
    Giordano, M.
    Moretto, R.
    Lonardi, S.
    Cremolini, C.
    ESMO OPEN, 2022, 7 (03)
  • [42] Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
    Gallois, C.
    Bergen, E. S.
    Auclin, E.
    Pernot, S.
    Higue, J.
    Trouilloud, I.
    Touchefeu, Y.
    Turpin, A.
    Mazard, T.
    Sartore-Bianchi, A.
    Prenen, H.
    Alberti, A.
    Pilla, L.
    Cuissy, S.
    Wookey, V.
    Perret, A.
    Melchior, C.
    Artru, P.
    Dubreuil, O.
    Drouillard, A.
    Doat, S.
    Lavole, J.
    Basile, D.
    Perkins, G.
    Jary, M.
    Stintzing, S.
    Jos, J.
    Tougeron, D.
    Taieb, J.
    ESMO OPEN, 2024, 9 (09)
  • [43] Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer - Polish multicenter experience
    Radecka, Barbara
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 308 - 308
  • [44] Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma
    Rose, A. A. N.
    DRUGS OF TODAY, 2019, 55 (04) : 247 - 264
  • [45] Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases
    Buchanan, Daniel D.
    Win, Aung K.
    Walsh, Michael D.
    Walters, Rhiannon J.
    Clendenning, Mark
    Nagler, Belinda
    Pearson, Sally-Ann
    Macrae, Finlay A.
    Parry, Susan
    Arnold, Julie
    Winship, Ingrid
    Giles, Graham G.
    Lindor, Noralane M.
    Potter, John D.
    Hopper, John L.
    Rosty, Christophe
    Young, Joanne P.
    Jenkins, Mark A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 917 - 926
  • [46] TRESBIEN (OGSG 2101): Encorafenib, binimetinib and cetuximab for early relapse stage II/III BRAF V600E-mutated CRC
    Boku, S.
    Satake, H.
    Ohta, T.
    Mitani, S.
    Kawakami, K.
    Matsumoto, T.
    Yamazaki, E.
    Hasegawa, H.
    Ikoma, T.
    Uemura, M.
    Yamaguchi, T.
    Ishizuka, Y.
    Kurokawa, Y.
    Sakai, D.
    Kawakami, H.
    Shimokawa, T.
    Tsujinaka, T.
    Kato, T.
    Satoh, T.
    Kagawa, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S735 - S736
  • [47] BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
    Di Nicolantonio, F.
    Martini, M.
    Molinari, F.
    Bianchi, A. Sartore
    Arena, S.
    Saletti, P.
    Mazzucchelli, L.
    Frattini, M.
    Siena, S.
    Bardelli, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 81 - 81
  • [48] Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas
    Travaglino, Antonio
    D'Armiento, Francesco P.
    Cassese, Gianluca
    Campanino, Maria R.
    Borrelli, Giorgio
    Pignatiello, Sara
    Luglio, Gaetano
    Maione, Francesco
    De Palma, Giovanni D.
    D'Armiento, Maria
    HISTOPATHOLOGY, 2019, 75 (02) : 160 - 173
  • [49] Targeting specific metabolic gene in BRAF V600E-mutated colorectal cancer
    Nishida, Naohiro
    Yukimoto, Ryohei
    Takeda, Mitsunobu
    Sekido, Yuki
    Hata, Tsuyoshi
    Wada, Noriko
    Hamabe, Atsushi
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Uemura, Mamoru
    Yamamoto, Hirofumi
    Satoh, Taroh
    Doki, Yuichiro
    Eguchi, Hidetoshi
    CANCER SCIENCE, 2025, 116 : 1354 - 1354
  • [50] Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
    Ros, J.
    Matito, J.
    Villacampa, G.
    Comas, R.
    Garcia, A.
    Martini, G.
    Baraibar, I.
    Saoudi, N.
    Salva, F.
    Martin, A.
    Antista, M.
    Toledo, R.
    Martinelli, E.
    Pietrantonio, F.
    Boccaccino, A.
    Cremolini, C.
    Dientsmann, R.
    Tabernero, J.
    Vivancos, A.
    Elez, E.
    ANNALS OF ONCOLOGY, 2023, 34 (06) : 543 - 552
12345